Alberta Investment Management Corp Replimune Group, Inc. Transaction History

Alberta Investment Management Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$25.43 - $34.25 $1.27 Million - $1.71 Million	-50,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$28.98 - $39.54 $869,400 - $1.19 Million	-30,000 Reduced 37.5%	50,000 $1.48 Million
Q2 2021 Aug 16, 2021	BUY	$28.5 - $39.37 $2.28 Million - $3.15 Million	80,000 New	80,000 $3.07 Million

150

68.3M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $562M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Alberta Investment Management Corp with notifications on news.